BG Medicine +24%, says clinical study shows performance of automated VIDAS

|About: BG Medicine, Inc. (BGMD)|By:, SA News Editor

BG Medicine (BGMD +24.3%) shoots higher after announcing results of a clinical research study which validate the analytical and clinical performance of the automated VIDAS Galectin-3 assay that was developed by BHMD partner bioMérieux SA.

BGMD says measurement values obtained with the VIDAS Galectin-3 assay were found to be in excellent agreement with those obtained with the BGM Galectin-3 Test.